Pituitary volume in teenagers with first-presentation borderline personality disorder

Psychiatry Research - Neuroimaging

Volumn 156, Issue 3, 2007, Pages 257-261

  Garner, Belinda ^a   Chanen, Andrew M ^a,b   Phillips, Lisa ^a   Velakoulis, Dennis ^a   Wood, Stephen J ^a,c   Jackson, Henry J ^a   Pantelis, Christos ^a   McGorry, Patrick D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Childhood trauma; HPA axis; MRI

Indexed keywords

CITALOPRAM; METHADONE; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; BORDERLINE STATE; CHILDHOOD INJURY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOTRAUMA; SELF REPORT; SYMPTOMATOLOGY;

ADOLESCENT; BORDERLINE PERSONALITY DISORDER; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY GLAND; PITUITARY-ADRENAL SYSTEM; STRESS DISORDERS, POST-TRAUMATIC;

EID: 36248987342     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2007.05.001     Document Type: Article

References (29)

1. Axelson D.A., Doraiswamy P.M., Boyko O.B., Rodrigo Escalona P., McDonald W.M., Ritchie J.C., Patterson L.J., Ellinwood Jr. E.H., Nemeroff C.B., and Krishnan K.R. In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. Psychiatry Research 44 (1992) 63-70
2. Baxter L., Edell W., Gerner R., Fairbanks L., and Gwirtsman H. Dexamethasone suppression test and axis I diagnoses of inpatients with DSM-III borderline personality disorder. Journal of Clinical Psychiatry 45 (1984) 150-153
3. Carrasco J.L., Diaz-Marsa M., Ignacio Pastrana J., Molina R., Brotons L., and Horcajadas C. Enhanced suppression of cortisol after dexamethasone in borderline personality disorder. A pilot study. Actas Espanolas de Psiquiatria: Acepsi 31 (2003) 138-141
4. Chanen A.M., Jovev M., and Jackson H.J. Adaptive functioning and psychiatric symptoms in adolescents with borderline personality disorder. Journal of Clinical Psychiatry 68 (2007) 297-306
5. De la Fuente J.M., and Mendlewicz J. TRH stimulation and dexamethasone suppression in borderline personality disorder. Biological Psychiatry 40 (1996) 412-418
6. De la Fuente J.M., Bobes J., Vizuete C., and Mendlewicz J. Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression. Journal of Psychiatric Research 36 (2002) 137-145
7. Dilsaver S.C., and Greden J.F. The DST in borderline patients. American Journal of Psychiatry 140 (1983) 1540-1541
8. Doraiswamy P.M., Krishnan K.R., Figiel G.S., Husain M.M., Boyko O.B., Rockwell W.J., and Ellinwood Jr. E.H. A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biological Psychiatry 28 (1990) 110-116
9. First M.B., Gibbon M., Spitzer R.L., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Version (SCID-I/p) (1996), Biometrics Research Department, New York State Psychiatric Institute, New York
10. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Benjamin L.S. User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (1997), American Psychiatric Press, Washington, DC
11. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., Brewer W.J., Smith D.J., Dazzan P., Berger G.E., Yung A.R., van den Buuse M., Murray R., McGorry P.D., and Pantelis C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 58 (2005) 417-423
12. Gertz B.J., Contreras L.N., McComb D.J., Kovacs K., Tyrrell J.B., and Dallman M.F. Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 120 (1987) 381-388
13. Grossman R., Yehuda R., New A., Schmeidler J., Silverman J., Mitropoulou V., Sta. Maria N., Golier J., and Siever L. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression. American Journal of Psychiatry 160 (2003) 1291-1298
14. Heim C., and Nemeroff C.B. Neurobiology of early life stress: clinical studies. Seminars in Clinical Neuropsychiatry 7 (2002) 147-159
15. Kontaxakis V., Markianos M., Vaslamatzis G., Markidis M., Kanellos P., and Stefanis C. Multiple neuroendocrinological responses in borderline personality disorder patients. Acta Psychiatrica Scandinavica 76 (1987) 593-597
16. Krishnan K.R., Doraiswamy P.M., Lurie S.N., Figiel G.S., Husain M.M., Boyko O.B., Ellinwood Jr. E.H., and Nemeroff C.B. Pituitary size in depression. Journal of Clinical Endocrinology and Metabolism 72 (1991) 256-259
17. Lahmeyer H.W., Val E., Gaviria F.M., Prasad R.B., Pandey G.N., Rodgers P., Weiler M.A., and Altman E.G. EEG sleep, lithium transport, dexamethasone suppression, monoamine oxidase activity in borderline personality disorder. Psychiatry Research 25 (1988) 19-30
18. Lange W., Wulff H., Berea C., Beblo T., Saavedra A.S., Mensebach C., Wingenfeld K., and Driessen M. Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology 30 (2005) 919-923
19. Lieb K., Rexhausen J.E., Kahl K.G., Schweiger U., Philipsen A., Hellhammer D.H., and Bohus M. Increased diurnal salivary cortisol in women with borderline personality disorder. Journal of Psychiatric Research 38 (2004) 559
20. Macmaster F.P., Russell A., Mirza Y., Keshavan M.S., Banerjee S.P., Bhandari R., Boyd C., Lynch M., Rose M., Ivey J., Moore G.J., and Rosenberg D.R. Pituitary volume in pediatric obsessive-compulsive disorder. Biological Psychiatry 59 (2006) 252-257
21. Macmaster F.P., Russell A., Mirza Y., Keshavan M.S., Taormina S.P., Bhandari R., Boyd C., Lynch M., Rose M., Ivey J., Moore G.J., and Rosenberg D.R. Pituitary volume in treatment-naive pediatric major depressive disorder. Biological Psychiatry 60 (2006) 862-866
22. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., Brewer W., Smith D.J., Dazzan P., Yung A.R., Zervas I.M., Christodoulou G.N., Murray R., McGorry P.D., and Pantelis C. Pituitary volume in psychosis. British Journal of Psychiatry 185 (2004) 5-10
23. Rinne T., De Kloet E., Wouters L., Goekoop J.G., DeRijk R.H., and van den Brink W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biological Psychiatry 52 (2002) 1102-1112
24. Sanchez M.M., Ladd C.O., and Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Development and Psychopathology 13 (2001) 419-449
25. Sassi R.B., Nicoletti M., Brambilla P., Harenski K., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., and Soares J.C. Decreased pituitary volume in patients with bipolar disorder. Biological Psychiatry 50 (2001) 271-280
26. Soloff P.H., George A., and Nathan R.S. The dexamethasone suppression test in patients with borderline personality disorders. American Journal of Psychiatry 139 (1982) 1621-1623
27. Velakoulis D., Wood S.J., Wong M.T., McGorry P.D., Yung A., Phillips L., Smith D., Brewer W., Proffitt T., Desmond P., and Pantelis C. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, ultra-high-risk individuals. Archives of General Psychiatry 63 (2006) 139-149
28. Westlund K.N., Aguilera G., and Childs G.V. Quantification of morphological changes in pituitary corticotropes produced by in vivo corticotropin-releasing factor stimulation and adrenalectomy. Endocrinology 116 (1985) 439-445
29. Zanarini M.C., Frankenburg F.R., Dubo E.D., Sickel A.E., Trikha A., Levin A., and Reynolds V. Axis I comorbidity of borderline personality disorder. American Journal of Psychiatry 155 (1998) 1733-1739